Letter to the editor: The association between the severity of erectile dysfunction and left ventricular diastolic dysfunction in patients with and without cardiovascular disease

To the editor:

The purpose of this study is to investigate erectile dysfunction (ED), a microvascular disorder, as a potential early indicator of cardiovascular disease (CVD). It is particularly focused on how ED is associated with left ventricular diastolic dysfunction (LVDD), an early sign of myocardial damage due to microvascular disorders. This aligns with growing research indicating that ED may be a symptom or precursor to more severe cardiovascular conditions [1].

The methodology involves a cross-sectional study of 123 patients with ED. The study is comprehensive, incorporating RigiScan for erectile assessment, conventional echocardiography for heart function analysis, and the International Index of Erectile Function (IIEF) questionnaire. The evaluation of ED severity is based on the penile base circumference changes and the duration of penile rigidity, which are objective quantitative parameters to quantify ED. This is in contrast to previous studies that used only the IIEF, a subjective ED measure [2]. In fact, it is very difficult to accurately quantify ED in clinical studies using only the IIEF questionnaire. It is worth noting that in the authors’ study, we found no statistical significance between IIEF scores and echocardiographic factors. These results are presumed to be due to the insufficient number of patients that could make a significant statistical difference, and the IIEF questionnaire itself is not an accurate objective indicator.

The results indicate a significant association between ED severity and LVDD, especially in patients with concurrent CVD. This finding is pivotal as it suggests that ED severity can be an independent risk factor for LVDD. The statistical significance of these results (p<0.001 in multivariate linear regression) underscores the strength of the association. This is in line with recent studies that have also found a correlation between ED and cardiovascular risk factors or conditions.

In conclusion, this study highlights the potential of ED assessment as an early indicator of CVD development. This aligns with current research trends that emphasize the importance of early detection and multidisciplinary approaches in managing conditions like ED and CVD [3,4]. The study’s findings are significant in the context of preventive healthcare, suggesting that monitoring and treating ED could also have implications for cardiovascular health.

In comparison to recent similar studies, this research stands out in its methodological approach and the strength of its findings. While the relationship between ED and cardiovascular health has been an ongoing subject of research, this study's specific focus on LVDD provides new insights into the specific mechanisms that might link these two conditions. Its methodology, using a combination of RigiScan, echocardiography, and IIEF, offers a comprehensive approach to understanding this relationship. Furthermore, the statistical significance and the focus on the independent risk factor of ED for LVDD add new dimensions to the existing body of knowledge.

Overall, this study is a valuable contribution to the ongo ing research on the interconnectedness of ED and cardiovascular health, highlighting the importance of integrated approaches in medical assessment and treatment.